12:00 AM
 | 
Sep 15, 2008
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

FluoroPharma preclinical data

In human prostate tumor cell lines, CardioPET had high uptakes that increased as a function of time. At 30, 60...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >